Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on investment. The trailing-twelve-month return on investment at Nymox Pharmaceutical

is 73.80%. Nymox Pharmaceutical's revenue for the same period is $3.30 million. The trailing-twelve-month return on investment at Meridian Bioscience

is 24.50%. Meridian Bioscience's EPS for the same period is $0.88. The trailing-twelve-month return on investment at IDEXX Laboratories

is 20.20%. Laboratories' PEG ratio is 2.59. The trailing-twelve-month return on investment at SurModics

is 13.60%. SurModics' profit margin for the same period is 23.20%.